Loading...

We've got a brand new version of Simply Wall St! Try it out

North Bud Farms

CNSX:NBUD
Snowflake Description

Adequate balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
NBUD
CNSX
CA$16M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

North Bud Farms Inc., through its subsidiaries, focuses on the production of pharmaceutical-grade cannabis and food grade cannabinoid infused inputs for the pharmaceutical and recreational cannabis markets in Canada. The last earnings update was 62 days ago. More info.


Add to Portfolio Compare Print
NBUD Share Price and Events
7 Day Returns
4.1%
CNSX:NBUD
-5.9%
CA Pharmaceuticals
1.3%
CA Market
1 Year Returns
-31.1%
CNSX:NBUD
-46.7%
CA Pharmaceuticals
-0.1%
CA Market
NBUD Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
North Bud Farms (NBUD) 4.1% -1.9% -12.1% -31.1% - -
CA Pharmaceuticals -5.9% -3.4% -24.8% -46.7% 217.3% 286.4%
CA Market 1.3% 4.2% 1.6% -0.1% 8.4% 5.7%
1 Year Return vs Industry and Market
  • NBUD outperformed the Pharmaceuticals industry which returned -46.7% over the past year.
  • NBUD underperformed the Market in Canada which returned -0.1% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

NBUD Value

 Is North Bud Farms undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for North Bud Farms. This is due to cash flow or dividend data being unavailable. The share price is CA$0.255.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for North Bud Farms's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are North Bud Farms's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:NBUD PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-05-31) in CAD CA$-0.04
CNSX:NBUD Share Price ** CNSX (2019-09-20) in CAD CA$0.26
Canada Pharmaceuticals Industry PE Ratio Median Figure of 13 Publicly-Listed Pharmaceuticals Companies 15.3x
Canada Market PE Ratio Median Figure of 539 Publicly-Listed Companies 14.14x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of North Bud Farms.

CNSX:NBUD PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:NBUD Share Price ÷ EPS (both in CAD)

= 0.26 ÷ -0.04

-5.76x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • North Bud Farms is loss making, we can't compare its value to the CA Pharmaceuticals industry average.
  • North Bud Farms is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does North Bud Farms's expected growth come at a high price?
Raw Data
CNSX:NBUD PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -5.76x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.56x
Canada Market PEG Ratio Median Figure of 245 Publicly-Listed Companies 1.02x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for North Bud Farms, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on North Bud Farms's assets?
Raw Data
CNSX:NBUD PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-05-31) in CAD CA$0.11
CNSX:NBUD Share Price * CNSX (2019-09-20) in CAD CA$0.26
Canada Pharmaceuticals Industry PB Ratio Median Figure of 151 Publicly-Listed Pharmaceuticals Companies 2.36x
Canada Market PB Ratio Median Figure of 2,457 Publicly-Listed Companies 1.43x
CNSX:NBUD PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:NBUD Share Price ÷ Book Value per Share (both in CAD)

= 0.26 ÷ 0.11

2.33x

* Primary Listing of North Bud Farms.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • North Bud Farms is good value based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess North Bud Farms's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. North Bud Farms has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

NBUD Future Performance

 How is North Bud Farms expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as North Bud Farms has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
97.7%
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is North Bud Farms expected to grow at an attractive rate?
  • Unable to compare North Bud Farms's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare North Bud Farms's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare North Bud Farms's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:NBUD Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 97.7%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 56.5%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.6%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:NBUD Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:NBUD Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-05-31 -1 -2
2019-02-28 -1 -2
2018-11-30 0 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if North Bud Farms is high growth as no earnings estimate data is available.
  • Unable to determine if North Bud Farms is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:NBUD Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from North Bud Farms Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:NBUD Past Financials Data
Date (Data in CAD Millions) EPS *
2019-05-31 -0.04
2019-02-28 -0.04
2018-11-30 -0.05

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if North Bud Farms will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine North Bud Farms's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. North Bud Farms's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  3. North Bud Farms's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess North Bud Farms's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
North Bud Farms has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

NBUD Past Performance

  How has North Bud Farms performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare North Bud Farms's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • North Bud Farms does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare North Bud Farms's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare North Bud Farms's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
North Bud Farms's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from North Bud Farms Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:NBUD Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-05-31 -2.32 2.35
2019-02-28 -2.05 2.07
2018-11-30 -1.80 1.82

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if North Bud Farms has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if North Bud Farms has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if North Bud Farms improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess North Bud Farms's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
North Bud Farms has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

NBUD Health

 How is North Bud Farms's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up North Bud Farms's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • North Bud Farms is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • North Bud Farms has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of North Bud Farms's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • North Bud Farms has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from North Bud Farms Company Filings, last reported 3 months ago.

CNSX:NBUD Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-05-31 6.08 0.00 0.75
2019-02-28 6.41 0.00 2.20
2018-11-30 6.68 0.00 4.02
  • North Bud Farms has no debt.
  • North Bud Farms has not taken on any debt in the past 5 years.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • North Bud Farms has less than a year of cash runway based on current free cash flow.
  • North Bud Farms has less than a year of cash runway if free cash flow continues to grow at historical rates of 200.7% each year.
X
Financial health checks
We assess North Bud Farms's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. North Bud Farms has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

NBUD Dividends

 What is North Bud Farms's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from North Bud Farms dividends.
If you bought CA$2,000 of North Bud Farms shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate North Bud Farms's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate North Bud Farms's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:NBUD Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.8%
Canada Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as North Bud Farms has not reported any payouts.
  • Unable to verify if North Bud Farms's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of North Bud Farms's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as North Bud Farms has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess North Bud Farms's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can North Bud Farms afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. North Bud Farms has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

NBUD Management

 What is the CEO of North Bud Farms's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Ryan Brown
AGE 38
CEO Bio

Mr. Ryan Brown has been Chief Executive Officer and President of GrowPros MMP Inc. since March 2014. Mr. Brown served as Chief Executive Officer and President of GrowPros Cannabis Ventures Inc. since January 1, 2015. Mr. Brown served as Chief Executive Officer, President and Director of Mazorro Resources Inc., since January 1, 2015. Mr. Brown has worked in the medical cannabis production industry for 10 years. He has been a licensed grower for 5 years and has extensive experience distributing hydroponic growing equipment and fertilizer throughout North America. He has been a Director of GrowPros MMP Inc. since March 2014. He served as a Director of GrowPros Cannabis Ventures Inc. until September 19, 2016. He also works as a real estate broker with Century 21 since September 2011. He obtained a BA in communication from University of Ottawa and holds a Quebec residential and commercial real estate licence.

CEO Compensation
  • Insufficient data for Ryan to compare compensation growth.
  • Insufficient data for Ryan to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team

Ryan Brown

TITLE
CEO & Director
AGE
38

Brendan Stutt

TITLE
Chief Financial Officer

Edward Miller

TITLE
VP of IR & Communications

Magda Farid

TITLE
Head of Quality Assurance and Compliance
TENURE
0.9 yrs

Kosta Kostic

TITLE
Secretary
AGE
44
Board of Directors

André Audet

TITLE
Chairman of the Board
AGE
57

Ryan Brown

TITLE
CEO & Director
AGE
38

Leona Aglukkaq

TITLE
Independent Director
AGE
51

Michael Saxon

TITLE
Independent Director

Teresa DeLuca

TITLE
Independent Director
AGE
53
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by North Bud Farms individual insiders in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
10. Sep 19 Buy Ryan Brown Individual 04. Sep 19 06. Sep 19 14,000 CA$0.25 CA$3,377
27. Aug 19 Buy Ryan Brown Individual 21. Aug 19 26. Aug 19 18,000 CA$0.26 CA$4,538
22. Aug 19 Buy Ryan Brown Individual 19. Aug 19 20. Aug 19 6,000 CA$0.28 CA$1,634
08. Aug 19 Buy Ryan Brown Individual 02. Aug 19 02. Aug 19 6,000 CA$0.25 CA$1,472
29. Jul 19 Buy Ryan Brown Individual 26. Jul 19 26. Jul 19 2,500 CA$0.27 CA$675
23. Jun 19 Buy Ryan Brown Individual 18. Jun 19 21. Jun 19 37,500 CA$0.28 CA$9,963
21. Jun 19 Buy North Bud Capital Holdings Ltd. Company 19. Jun 19 19. Jun 19 3,333,333 CA$0.30 CA$1,000,001
17. Jun 19 Buy Ryan Brown Individual 12. Jun 19 13. Jun 19 9,500 CA$0.27 CA$2,529
12. Jun 19 Buy Ryan Brown Individual 31. May 19 04. Jun 19 9,000 CA$0.28 CA$2,501
28. May 19 Buy North Bud Capital Holdings Ltd. Company 17. May 19 17. May 19 84,500 CA$0.30 CA$24,410
21. May 19 Buy Ryan Brown Individual 16. May 19 17. May 19 3,000 CA$0.30 CA$886
06. May 19 Buy Ryan Brown Individual 01. May 19 01. May 19 5,000 CA$0.33 CA$1,650
02. Apr 19 Buy Ryan Brown Individual 27. Mar 19 01. Apr 19 12,700 CA$0.34 CA$4,176
27. Mar 19 Buy Ryan Brown Individual 21. Mar 19 25. Mar 19 7,000 CA$0.38 CA$2,512
03. Dec 18 Buy Ryan Brown Individual 28. Nov 18 28. Nov 18 37,000 CA$0.26 CA$8,870
04. Feb 19 Buy Ryan Brown Individual 25. Jan 19 25. Jan 19 2,000 CA$0.25 CA$490
28. Jan 19 Buy Ryan Brown Individual 22. Jan 19 23. Jan 19 36,500 CA$0.25 CA$8,672
01. Jan 19 Buy Ryan Brown Individual 24. Dec 18 27. Dec 18 16,500 CA$0.22 CA$3,443
22. Dec 18 Buy Ryan Brown Individual 17. Dec 18 19. Dec 18 12,000 CA$0.21 CA$2,435
11. Dec 18 Buy Ryan Brown Individual 05. Dec 18 05. Dec 18 16,000 CA$0.24 CA$3,643
04. Dec 18 Buy André Audet Individual 28. Nov 18 28. Nov 18 74,000 CA$0.25 CA$18,500
29. Nov 18 Buy Ryan Brown Individual 23. Nov 18 27. Nov 18 46,500 CA$0.26 CA$11,525
23. Nov 18 Buy Ryan Brown Individual 20. Nov 18 22. Nov 18 30,000 CA$0.26 CA$7,688
18. Nov 18 Buy Ryan Brown Individual 14. Nov 18 14. Nov 18 15,000 CA$0.26 CA$3,695
02. Nov 18 Buy Ryan Brown Individual 31. Oct 18 31. Oct 18 5,000 CA$0.27 CA$1,325
22. Oct 18 Buy Ryan Brown Individual 17. Oct 18 17. Oct 18 17,000 CA$0.38 CA$6,200
16. Oct 18 Buy Ryan Brown Individual 11. Oct 18 11. Oct 18 4,000 CA$0.40 CA$1,600
10. Oct 18 Buy Ryan Brown Individual 05. Oct 18 05. Oct 18 11,000 CA$0.44 CA$4,835
28. Sep 18 Sell Kosta Kostic Individual 26. Sep 18 26. Sep 18 -40,000 CA$0.56 CA$-22,400
26. Sep 18 Buy Ryan Brown Individual 24. Sep 18 24. Sep 18 10,000 CA$0.34 CA$3,400
X
Management checks
We assess North Bud Farms's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. North Bud Farms has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

NBUD News

Simply Wall St News

What Kind Of Investor Owns Most Of North Bud Farms Inc. (CNSX:NBUD)?

See our latest analysis for North Bud Farms CNSX:NBUD Ownership Summary, August 15th 2019 What Does The Lack Of Institutional Ownership Tell Us About North Bud Farms? … Private Company Ownership Our data indicates that Private Companies hold 27%, of the company's shares. … Public Company Ownership We can see that public companies hold 25%, of the NBUD shares on issue.

Simply Wall St -

NBUD Company Info

Description

North Bud Farms Inc., through its subsidiaries, focuses on the production of pharmaceutical-grade cannabis and food grade cannabinoid infused inputs for the pharmaceutical and recreational cannabis markets in Canada. The company was incorporated in 2016 and is based in Toronto, Canada.

Details
Name: North Bud Farms Inc.
NBUD
Exchange: CNSX
Founded: 2016
CA$16,177,660
63,441,806
Website: http://www.northbud.com
Address: North Bud Farms Inc.
181 Bay Street,
Suite 4400,
Toronto,
Ontario, M5J 2T3,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX NBUD Class A Common Shares Canadian National Stock Exchange CA CAD 20. Sep 2018
OTCPK NOBD.F Class A Common Shares Pink Sheets LLC US USD 20. Sep 2018
Number of employees
Current staff
Staff numbers
0
North Bud Farms employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/22 00:52
End of day share price update: 2019/09/20 00:00
Last earnings filing: 2019/07/22
Last earnings reported: 2019/05/31
Last annual earnings reported: 2018/11/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.